Inventor · disambiguated record
Hongchang Qu
Also filed as: QU HONGCHANG
17 granted patents·8 pending applications·88 citations·filing 2010–2025
92Inventor score
Top patents by PatentIndex Score
25 records- 0194US9371365B2Modified compstatin with peptide backbone and C-terminal modificationsUNIV PENNSYLVANIA·Filed 2015·Granted Jun 21, 2016·22 cites·19 claims
- 0293US11542313B2Incretin analogs and uses thereofLILLY CO ELI·Filed 2018·Granted Jan 3, 2023·7 cites·26 claims
- 0393US8946145B2Modified compstatin with peptide backbone and C-terminal modificationsLAMBRIS JOHN D·Filed 2010·Granted Feb 3, 2015·26 cites·23 claims
- 0492US11254721B2GIPR-agonist compoundsLILLY CO ELI·Filed 2020·Granted Feb 22, 2022·5 cites·3 claims
- 0591US11897926B2GIPR-agonist compoundsLILLY CO ELI·Filed 2022·Granted Feb 13, 2024·3 cites·4 claims
- 0691US10174079B2Compstatin analogs with improved pharmacokinetic propertiesUNIV PENNSYLVANIA·Filed 2017·Granted Jan 8, 2019·4 cites·8 claims
- 0788US11084861B2GIP/GLP1 co-agonist compoundsLILLY CO ELI·Filed 2019·Granted Aug 10, 2021·6 cites·10 claims
- 0886US9630992B2Compstatin analogs with improved pharmacokinetic propertiesLAMBRIS JOHN D·Filed 2012·Granted Apr 25, 2017·4 cites·20 claims
- 0985US12371465B2Incretin analogs and uses thereofLILLY CO ELI·Filed 2024·Granted Jul 29, 2025·0 cites·10 claims
- 1084US9938335B2Glucagon and GLP-1 co-agonist compoundsLILLY CO ELI·Filed 2016·Granted Apr 10, 2018·6 cites·21 claims
- 1182US11834486B2Incretin analogs and uses thereofLILLY CO ELI·Filed 2018·Granted Dec 5, 2023·3 cites·22 claims
- 1281US12365716B2Incretin analogs and uses thereofLILLY CO ELI·Filed 2022·Granted Jul 22, 2025·0 cites·14 claims
- 1380US10745442B2Compstatin analogs with improved pharmacokinetic propertiesUNIV PENNSYLVANIA·Filed 2018·Granted Aug 18, 2020·2 cites·20 claims
- 1480US2025313605A1Incretin analogs and uses thereofLILLY CO ELI·Filed 2025·Application pending·0 cites
- 1578US2025051415A1Gip/glp1 co-agonist compoundsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1677US11541123B2Dual amylin and calcitonin receptor agonists and uses thereofLILLY CO ELI·Filed 2021·Granted Jan 3, 2023·0 cites·13 claims
- 1773US2024218031A1Gipr-agonist compoundsLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1871US12115210B2Long acting amylin receptor agonists and uses thereofLILLY CO ELI·Filed 2022·Granted Oct 15, 2024·0 cites·20 claims
- 1970US2024190936A1Incretin Analogs and Uses ThereofLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2069US12252524B2GIP/GLP1 co-agonist compoundsLILLY CO ELI·Filed 2021·Granted Mar 18, 2025·0 cites·20 claims
- 2166US2021032291A1Compstatin Analogs With Improved Pharmacokinetic PropertiesUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2265US2024270821A1Gip/glp1/gcg tri-receptor agonists and uses thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2364US2025163119A1Compounds for the treatment of diabetes or obesityLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2452US12410227B2Incretin analogs and uses thereofLILLY CO ELI·Filed 2020·Granted Sep 9, 2025·0 cites·33 claims
- 2550US2023265151A1Gip/glp1 co-agonist compoundsLILLY CO ELI·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hongchang Qu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →